glp 1 receptor agonists brand names PDB-101: Molecule of the Month: GLP-1 Prescribing Information for Glucagon-like Peptide-1

For colostomy and ileostomy users, slowed gut motility can meaningfully change output consistency and frequency

Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises

Abstract Background: The benefit of first-line use of sodium-dependent glucose transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes mellitus (T2DM) with low risk of cardiovascular diseases are not clear

Appetite & energy-balance research: experimental frameworks exploring hypothalamic melanocortin signaling in feeding behaviour and caloric-intake models